EP1499373A2 — Medicament dispenser
Assigned to Glaxo Group Ltd · Expires 2005-01-26 · 21y expired
What this patent protects
There is provided a medicament dispenser comprising a housing having an outlet; a medicament container locatable within said housing; an electronic dose counter associated with said outlet; wherein said dose release dispensable from said medicament container through said outlet; …
USPTO Abstract
There is provided a medicament dispenser comprising a housing having an outlet; a medicament container locatable within said housing; an electronic dose counter associated with said outlet; wherein said dose release dispensable from said medicament container through said outlet; and means for detecting changes in the performance of the sensor attributable to contamination or degradation and for adjusting the operation of the dispenser to compensate, at least in part, for said changes.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.